Stock Events

Stock Events

Hikma Pharmaceuticals (HIK.LSE) Q3 2025 Earnings

7AugConfirmed

Q1 2024

Q3 2024

Q1 2025

Q3 2025

75.82

83.76

91.7

99.63

Details

Expected EPS

83.63475

Actual EPS

90.69724

Surprise EPS

7.06

Surprise Percent

+8.44%

Description

Hikma Pharmaceuticals (HIK.LSE) has reported earnings of 90.69724 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.